Trial
NCT02815397
DA-EPOCH-Rituximab/Metformin (RM) for Double Hit Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rush University Medical Center
Collaborators
Elsa U. Pardee Foundation
Condition
Diffuse Large B-Cell Lymphoma
Intervention
Metformin
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-17